Aug 2026· BioNanoScience· Vol 16· 0 citations· 153 references
TL;DR
Dendrimer-based systems have shown considerable potential to remodel the tumor microenvironment, induce immunogenic cell death, enhance immune activation, and facilitate combination therapies, offering promising opportunities to improve cancer diagnosis, treatment, and patient outcomes.
This review examines the main classes of nanoplatforms currently explored for cancer therapy, including inorganic, polymeric, lipid-based, and hybrid organic–inorganic systems, and considers emerging directions in AI-guided nanoparticle engineerization design and natural-compound-based nanomedicines, both of which are...
C. Boncristiani, F. Baldassarre, Khadija Eddahaoui et al.· Materials· 0 citations
This review comprehensively examines recent advancements in dendrimer-mediated delivery systems, elucidating their capacity to optimize solubility, enhance bioavailability, and facilitate the site-specific targeting of therapeutic payloads and offers crucial insights into overcoming translational bottlenecks in targete...
Smit Saha, Solagiri Mouli, Suresh Mamidi et al.· Russian journal of bioorgani...· 0 citations
Dendrimers are a highly adaptable and promising family of next-generation nanocarriers with great potential for precise drug delivery and improved therapeutic applications, and continued efforts toward developing safer and biodegradable dendrimer architectures are imperative to facilitate their successful integration i...
Abdul Shadab, Abdul Faiz Ansari, O. Alshogran· Current Nanomedicine· 0 citations
Major nanocarrier platforms are examined, with particular emphasis on their tunable physicochemical properties and modular architectures that facilitate adaptation to diverse patient populations, including elderly patients and those with treatment-resistant conditions.
Devesh U. Kapoor, Anil Pareek, Jigal Hirawala et al.· Pharmaceutical Sciences Asia· 0 citations
In conclusion, while nanocarriers offer significant advancements in targeted cancer therapy, their successful clinical implementation depends on overcoming various scientific, technical, and regulatory challenges.
Busayo Olamide Tomoh· International Journal of Med...· 0 citations
Cancer remains a major global health challenge, and nanoparticle-based drug delivery systems have emerged as a promising strategy for targeted cancer therapy. However, clinical translation is still limited by an incomplete understanding of how nanoparticles navigate the tumor microenvironment (TME) throughout the deliv...
Meng-Xin Ban, Si-Fang Zhao, Zi-Yu Liu et al.· Pharmaceutics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.